Reported Jan 19, 2022 · Terminated

Metformin 750 mg Extended Release NDC # 70518-2920-00

RemedyRepack Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: RemedyRepack Inc. · 625 Kolter Dr Ste 4 · Indiana, PA · 15701-3571

Is this the product you have?

  • Metformin 750 mg Extended Release NDC # 70518-2920-00
Lot codes and dates
    • Lot # J0511265-021121
    • exp. date 02/28/2022 J0499451-122220
    • exp. date 01/31/2022 J0496563-120820
    • exp. date 12/31/2021 J0495111-120120
    • exp. date 12/31/2021
Amount recalled
56 Blister Cards

Where it was sold

Why it was recalled

CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new RemedyRepack Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 28, 2022 · Data as of Sep 19, 7:01 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.